Angiogenesis Inhibitors: all 4,430 studies that test it

Page 20 of 45. Open to participants first (542), then studies with results posted, then the rest; newest registration first within each.

• Bevacizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaCompletedNCT00290810Phase 2Results posted
• Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By SurgeryCompletedNCT00290615Phase 2Results posted
• Bevacizumab in Treating Patients With AngiosarcomaCompletedNCT00288015Phase 2Results posted
• Bortezomib and Thalidomide in Treating Patients With Newly Diagnosed Stage II or Stage III Multiple MyelomaCompletedNCT00287872Phase 2Results posted
• REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid CarcinomasCompletedNCT00287287Phase 2Results posted
• Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular CarcinomaCompletedNCT00287222Phase 2Results posted
• Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung AdenocarcinomaCompletedNCT00284141Phase 2Results posted
• Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular DegenerationCompletedNCT00284089Phase 1/2Results posted
• Safety and Efficacy of Ranibizumab in Diabetic Macular Edema With Center InvolvementCompletedNCT00284050Phase 2Results posted
• Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00281840Phase 2Results posted
• Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung CancerTerminatedNCT00281827Phase 2Results posted
• A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2)CompletedNCT00281697Phase 3Results posted
• Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast CancerTerminatedNCT00281528Phase 2Results posted
• Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)CompletedNCT00275821Phase 3Results posted
• Bevacizumab for Recurrent Malignant GliomaCompletedNCT00271609Phase 2Results posted
• Avastin/Docetaxel/Carboplatin in Non-Small Cell Lung CancerCompletedNCT00271505Phase 2Results posted
• Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By SurgeryTerminatedNCT00268450Phase 2Results posted
• Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal CancerCompletedNCT00267696Phase 2Results posted
• Lenalidomide (Revlimid) in Chronic Lymphocytic Leukemia (CLL)CompletedNCT00267059Phase 2Results posted
• Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal CancerCompletedNCT00265850Phase 3Results posted
• A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib AloneCompletedNCT00265317Phase 2Results posted
• Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT00262847Phase 3Results posted
• A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)Status unknownNCT00262067Phase 3Results posted
• Neoadjuvant Treatment of Breast CancerCompletedNCT00254592Phase 2Results posted
• Study of SU011248 in Patients With Advanced Kidney CancerCompletedNCT00254540Phase 2Results posted
• An International Phase 2 Study Of SU011248 In Patients With Inoperable Liver CancerCompletedNCT00247676Phase 2Results posted
• Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast CancerCompletedNCT00246571Phase 2Results posted
• Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast CancerCompletedNCT00243503Phase 2Results posted
• Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By SurgeryCompletedNCT00242502Phase 2Results posted
• Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.CompletedNCT00240071Phase 2Results posted
• Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to RituximabCompletedNCT00238238Phase 2Results posted
• Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell CancerCompletedNCT00234494Phase 2Results posted
• Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerCompletedNCT00234052Phase 2Results posted
• Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine TumorsTerminatedNCT00227617Phase 2/3Results posted
• Lenalidomide and Prednisone in Treating Patients With MyelofibrosisCompletedNCT00227591Phase 2Results posted
• Phase 2 Trial of Bevacizumab in Combination With PemetrexedCompletedNCT00227019Phase 2Results posted
• An International Phase 2 Study Of SU011248 In Patients With Advanced / Metastatic Gastric Cancer Failing ChemotherapyCompletedNCT00226811Phase 2Results posted
• Study of Pemetrexed and Bevacizumab in Patients With Head and Neck CancerCompletedNCT00222729Phase 2Results posted
• A Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of LifeCompletedNCT00222105Phase 2Results posted
• Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon CancerCompletedNCT00217737Phase 3Results posted
• Docetaxel With Bevacizumab as First-Line Therapy in Treating Women With Stage IV Breast CancerCompletedNCT00217672Phase 2Results posted
• Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction CancerCompletedNCT00217581Phase 2Results posted
• Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell NeoplasmsCompletedNCT00217425Phase 2Results posted
• Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)TerminatedNCT00215943Phase 3Results posted
• Primary Systemic Therapy in Operable/Locally Advanced Breast CancerCompletedNCT00203502Phase 2Results posted
• Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus ErlotinibCompletedNCT00203424Phase 2Results posted
• Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal CancerCompletedNCT00203411Phase 2Results posted
• Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast CancerTerminatedNCT00195091Phase 2Results posted
• A Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkin's LymphomaCompletedNCT00193492Phase 2Results posted
• Irinotecan, Carboplatin and Radiation Therapy Followed by Bevacizumab in Limited Stage Small Cell Lung CancerCompletedNCT00193375Phase 2Results posted
• Bevacizumab, Erlotinib, and Imatinib in the Treatment of Advanced Renal Cell CarcinomaCompletedNCT00193258Phase 1/2Results posted
• Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal CancerCompletedNCT00193219Phase 2Results posted
• Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin's LymphomaCompletedNCT00179673Phase 2Results posted
• Safety And Efficacy Of Lenalidomide In Patients With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma (NHL)CompletedNCT00179660Phase 2Results posted
• Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple MyelomaCompletedNCT00179647Phase 3Results posted
• Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] AbnormalityCompletedNCT00179621Phase 3Results posted
• Safety and Efficacy Study Using Bevacizumab, Capecitabine and Oxaliplatin for Colorectal CancerCompletedNCT00177307Phase 2Results posted
• Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal CarcinomaCompletedNCT00176800Phase 2Results posted
• Study of Oxaliplatin, Capecitabine and Bevacizumab as First Line Treatment for Patients With Advanced Colorectal CancerCompletedNCT00159432Phase 2Results posted
• CC-5013 (Lenalidomide) and Rituximab in Waldenstrom's MacroglobulinemiaTerminatedNCT00142168Phase 2Results posted
• Thalidomide and Rituximab in Waldenstrom's MacroglobulinemiaCompletedNCT00142116Phase 2Results posted
• Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck CancerCompletedNCT00140556Early Phase 1Results posted
• Study Of SU011248 Administered On A Continuous Daily Dosing Schedule In Patients With Gastrointestinal Stromal TumorCompletedNCT00137449Phase 2Results posted
• Study Of SU011248 In Combination With Docetaxel (Taxotere) And Prednisone In Patients With Prostate CancerCompletedNCT00137436Phase 1/2Results posted
• Study Of SU011248 (Sunitinib) Given In A Continuous Daily Regimen In Patients With Advanced Renal Cell CancerCompletedNCT00137423Phase 2Results posted
• A Study to Evaluate the Efficacy of Bevacizumab in Combination With Tarceva for Advanced Non-Small Cell Lung CancerCompletedNCT00130728Phase 3Results posted
• Bevacizumab and Erlotinib Study in Advanced Ovarian CancerCompletedNCT00130520Phase 2Results posted
• Carboplatin Taxol Avastin in Ovarian Cancer (OVCA)CompletedNCT00129727Phase 2Results posted
• Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney CancerCompletedNCT00126503Phase 1/2Results posted
• Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney CancerCompletedNCT00126490Phase 2Results posted
• S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple MyelomaTerminatedNCT00124579Phase 2Results posted
• A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast CancerCompletedNCT00121836Phase 4Results posted
• Combination Chemo, Rituximab, and Bevacizumab in Older Patients With Stage II-IV Diffuse Large B-Cell LymphomaCompletedNCT00121199Phase 2Results posted
• Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast CancerCompletedNCT00119262Phase 2Results posted
• Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell TransplantActive, not recruitingNCT00114101Phase 3Results posted
• Study Of SU011248 Plus Gefitinib (Iressa) In Patients With Advanced Renal Cell CarcinomaCompletedNCT00113529Phase 1/2Results posted
• A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung CancerCompletedNCT00113516Phase 2Results posted
• Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal CancerCompletedNCT00113230Phase 2Results posted
• Neoadjuvant Clinical Trial to Evaluate the Efficacy of Bevacizumab for Renal Cell CarcinomaCompletedNCT00113217Phase 2Results posted
• Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon CancerCompletedNCT00112918Phase 3Results posted
• CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney CancerCompletedNCT00112840Phase 1/2Results posted
• Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple MyelomaCompletedNCT00112827Phase 1/2Results posted
• Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma MultiformeCompletedNCT00112502Phase 2Results posted
• Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone TherapyCompletedNCT00110214Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1TerminatedNCT00109772Phase 2Results posted
• Lenalidomide (Revlimid) to Treat Advanced Ocular MelanomaCompletedNCT00109005Phase 2Results posted
• Bevacizumab and Capecitabine as First-Line Therapy in Treating Older Patients With Metastatic Colorectal CancerTerminatedNCT00107315Phase 2Results posted
• Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.CompletedNCT00101686Phase 3Results posted
• Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal CancerCompletedNCT00100841Phase 2Results posted
• Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic CancerCompletedNCT00100815Phase 2Results posted
• Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or NeuroblastomaCompletedNCT00098865Phase 2Results posted
• Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple MyelomaActive, not recruitingNCT00098475Phase 3Results posted
• Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon CancerCompletedNCT00096278Phase 3Results posted
• Lenalidomide With or Without Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaCompletedNCT00096044Phase 2Results posted
• Fludarabine and Thalidomide in Treating Patients With Newly Diagnosed Chronic Lymphocytic LeukemiaCompletedNCT00096018Phase 1/2Results posted
• CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemic AmyloidosisCompletedNCT00091260Phase 2Results posted
• PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney CancerTerminatedNCT00090870Phase 2Results posted
• SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell CarcinomaCompletedNCT00089648Phase 2Results posted
• A Phase II Study of CC-5013 in MyelofibrosisCompletedNCT00087672Phase 2Results posted
• DTPACE Followed by Tandem Transplant With Melphalan (MEL) 200 Versus MEL/Dexamethasone/Thalidomide (DT) Platinol/Adriamycin/Etoposide (PACE) Hybrid and DTPACE ConsolidationCompletedNCT00083915Phase 3Results posted

← Angiogenesis Inhibitors overview